Paolo Pucci

Chief Executive Officer, ARQULE INC.

Companies

Merus N.V.Board member Jul 2, 2020 to now¹
Replimune Group, Inc.Board member Apr 2, 2020 to now²
West Pharmaceutical Services (United States)Board member Sep 13, 2016 to now³
Trillium Therapeutics Inc.Board member Jan 4, 2021 to Nov 19, 2021⁴
LUMOS PHARMA, INC.Board member Nov 16, 2015 to May 25, 2018⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

West Pharmaceutical Services (United States) WST11,854 shares⁶$4.6M at $384.40May 4, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

May 4, 2026Granted 791 shares of West Pharmaceutical Services (United States)⁶
May 6, 2025Granted 1,071 shares of West Pharmaceutical Services (United States)⁷
Apr 23, 2024Granted 564 shares of West Pharmaceutical Services (United States)⁸
Apr 25, 2023Granted 616 shares of West Pharmaceutical Services (United States)⁹
May 24, 2022Granted 632 shares of West Pharmaceutical Services (United States)¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMerus N.V., Board member
2
SEC EDGARReplimune Group, Inc., Board member
3
SEC EDGARWest Pharmaceutical Services (United States), Board member
4
SEC EDGARTrillium Therapeutics Inc., Board member
5
SEC EDGARLUMOS PHARMA, INC., Board member
6
SEC EDGARWest Pharmaceutical Services (United States) shares after the filing of May 4, 2026
7
SEC EDGARForm 4 filed May 8, 2025
8
SEC EDGARForm 4 filed Apr 25, 2024
9
SEC EDGARForm 4 filed Apr 27, 2023
10
SEC EDGARForm 4 filed May 26, 2022